U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06997562) titled 'Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine' on May 21.
Brief Summary: This study compares the effectiveness of greater occipital nerve blockade and sphenopalatine ganglion blockade in reducing headache intensity, duration, frequency, and disability in patients with episodic migraine.
Study Start Date: May 01, 2024
Study Type: INTERVENTIONAL
Condition:
Greater Occipital Nerve Block
Sphenopalatine Ganglion Block
Episodic Migraine
Intervention:
OTHER: Greater occipital nerve blockade
Patients will receive greater occipital nerve blockade using 2 mL of 2% lidocaine at t...